One major trial, known as the STEP program, looked at the impact of Semaglutide on overweight and obese people without diabetes
Hwu WL, Chien YH, Tang NL, Law LK, Lin CY, Lee NC
As your body loses weight rapidly, skin elasticity and collagen production may shift, potentially causing temporary dryness, itching, or mild irritation in some individuals
One significant finding is from the SELECT trial, which showed that long-term use of semaglutide in individuals with obesity but without diabetes led to a 20% reduction in major cardiovascular events and an average weight loss of 9.4%
15 This raises questions about sustainability, accessibility, as well as cost
The right supplements fill those gaps